Overview
Journal of Ocular Pharmacology and Therapeutics is the only multidisciplinary, peer-reviewed journal providing basic and clinical research about biopharmaceuticals that have the potential to prevent, treat, and/or diagnose ocular diseases and disorders. The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of biopharmaceuticals for the treatment of ophthalmic disorders.
Journal of Ocular Pharmacology and Therapeutics coverage includes:
- Glaucoma
- Cataracts
- Retinal degeneration
- Proliferative disorders of the eye
- Ocular infection, trauma, and toxicology
- Ocular drug delivery and biotransformation
- Ocular pharmacotherapy/clinical trials
- Gene therapy
- Ocular metabolic disorders
- Ocular ischemia and blood flow
- Ocular inflammatory and immune disorders
Journal of Ocular Pharmacology and Therapeutics is under the editorial leadership of Editor
W. Daniel Stamer, PhD, Duke University; Associate Editor David E. Potter, PhD, Medical University of South Carolina; and other leading investigators. View the entire editorial board.
Audience: Ophthalmologists, retinal cell biologists, and ocular disease specialists and researchers, among others
Society Affiliation
The Official Journal of the Association for Ocular Pharmacology and Therapeutics